We are live on
!
Find out more
CCM
Chiron Capital Management Portfolio holdings
AUM
$111M
This Fund
S&P 500
This Quarter
Est. Return
+0.26%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$124M
AUM Growth
–
Cap. Flow
+$128M
Cap. Flow
% of AUM
102.75%
Top 10 Holdings %
Top 10 Hldgs %
62.53%
Holding
516
New
512
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$47.2M |
| 2 |
Gilead Sciences
GILD
|
+$8.93M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$6.16M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$4.08M |
| 5 |
Pfizer
PFE
|
+$2.85M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 52.51% |
| 2 | Consumer Staples | 6.57% |
| 3 | Financials | 5.19% |
| 4 | Energy | 5.16% |
| 5 | Consumer Discretionary | 4.37% |
Similar funds
EGP
WWMP
HCM
FCU
NIM
SPWM
JE
VP
Chiron Capital Management's Q3 2020 Portfolio in Review
Q3 2020 is the first quarter with a 13F filing on record for Chiron Capital Management, which disclosed 516 positions worth $124M. Its ten largest holdings account for 63% of the portfolio.
Its largest position is Bristol-Myers Squibb: 784,079 shares worth $47.3M.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, followed by Consumer Staples and Financials.
- Chiron Capital Management's largest Q3 2020 buy was Bristol-Myers Squibb: 784,079 shares worth $47.3M.
- Chiron Capital Management's ten largest holdings make up 63% of its $124M portfolio in Q3 2020.
- Chiron Capital Management disclosed 516 positions in Q3 2020, its first 13F filing on record.
Based on Chiron Capital Management's 13F filing for Q3 2020, filed 19 Nov 2020.